You are here: Home » News-ANI » Business
Business Standard

Aurobindo completes acquisition of Apotex's businesses in 5 European countries


Aurobindo Pharma, a world-leading marketer and manufacturer of and active pharmaceutical ingredients, on Monday announced that it has closed the acquisition of Apotex's commercial operations and certain supporting infrastructure in five European countries.

The binding agreement to acquire five of Apotex' European businesses including infrastructure, personnel, products, certain established trademarks, marketing authorisations and dossier license rights in Poland, the Czech Republic, the (including the in Leiden), and was announced on July 14 last year.

acted as sole and LLP acted as to Aurobindo. India provided

Aurobindo's product portfolio is spread over seven major therapeutic/product areas encompassing antibiotics, antiretrovirals, CVS, CNS, gastroenterologicals, anti-allergies and anti-diabetics. The and are Aurobindo's two most important markets accounting for over 70 per cent of the company's 2.6 billion dollar sales.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Mon, February 11 2019. 12:45 IST